ACTG 5253: Observational Study of Specificity of Mycobacterium Tuberculosis Screening and Diagnostics in HIV-Infected Individuals
Not Applicable
Completed
- Conditions
- Health Condition 1: null- HIV-infections
- Registration Number
- CTRI/2010/091/001234
- Lead Sponsor
- AIDS Clinical Trials Group National Institute of Allergy and Infectious Diseases NIAID USA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 800
Inclusion Criteria
HIV-infected
Exclusion Criteria
Receipt of ART within 90 days prior to study entry
Diagnosis of active TB (pulmonary or extrapulmonary) within 90 days prior to study entry
Receipt of 7 or more cumulative days of certain medications within 90 days prior to study entry. More information on this criterion can be found in the protocol.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method